![]()
|
|
||||||||
(Received for publication, April 3, 1997, and in revised form, May 30, 1997)
From the Peptide epitopes presented through class I major
histocompatability complex (MHC class I) on the cell surface, are
generated by proteolytic processing of protein-antigens in the
cytoplasm. The length and amino acid sequence determine whether a given
peptide can fit into the peptide binding groove of class I heavy chain molecules and subsequently be presented to the immune system. The mode
of action of the processing pathway is therefore of great interest. To
study the processing mechanism of MHC class I-restricted intracellular
antigens, we reconstituted the proteolytic processing of a model
antigen in a cell-free system. Incubation of oxidized and urea-treated
OVA in lymphocyte lysate resulted in partial degradation of the
antigen. Degradation of the antigen depended on the presence of ATP.
Addition of methylated ubiquitin abolished the reaction which was then
restored by addition of an excess of native ubiquitin, indicating that
the breakdown of the antigen in lymphocyte lysate is mediated by the
ubiquitin proteolytic system. Upon incubation of modified OVA in
lymphocyte lysate, a specific antigenic peptide was generated. The
peptide was recognized by cytotoxic T lymphocytes directed against
OVA-derived, H-2Kb-restricted peptide (SIINFEKL), and
by a monoclonal antibody that recognizes cell-bound
Kb-SIINFEKL complexes. Formation of the peptide epitope
depended on the presence of ATP and ubiquitin. These results indicate
that proteolytic processing of modified OVA is carried out by the
ubiquitin-mediated degradation system. The experimental system
described provides a tool to analyze the molecular mechanisms
underlying the generation of specific, MHC class I-restricted peptide
epitopes.
Volume 272, Number 34,
Issue of August 22, 1997
pp. 21060-21066
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
,
,
,
Department of Biochemistry, George S. Wise
Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel
and the § Lymphocyte Biology Section, Laboratory of
Immunology, NIAID, National Institutes of Health,
Bethesda, Maryland 20892-1892
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W. M. Cohen, A. Bianco, F. Connan, L. Camoin, M. Dalod, G. Lauvau, E. Ferries, B. Culmann-Penciolelli, P. M. van Endert, J. P. Briand, et al. Study of Antigen-Processing Steps Reveals Preferences Explaining Differential Biological Outcomes of Two HLA-A2-Restricted Immunodominant Epitopes from Human Immunodeficiency Virus Type 1 J. Virol., September 11, 2002; 76(20): 10219 - 10225. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ben-Shahar, A. Komlosh, E. Nadav, I. Shaked, T. Ziv, A. Admon, G. N. DeMartino, and Y. Reiss 26 S Proteasome-mediated Production of an Authentic Major Histocompatibility Class I-restricted Epitope from an Intact Protein Substrate J. Biol. Chem., July 30, 1999; 274(31): 21963 - 21972. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. N. Emmerich, A. K. Nussbaum, S. Stevanovic, M. Priemer, R. E. M. Toes, H.-G. Rammensee, and H. Schild The Human 26 S and 20 S Proteasomes Generate Overlapping but Different Sets of Peptide Fragments from a Model Protein Substrate J. Biol. Chem., July 7, 2000; 275(28): 21140 - 21148. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Komlosh, F. Momburg, T. Weinschenk, N. Emmerich, H. Schild, E. Nadav, I. Shaked, and Y. Reiss A Role for a Novel Luminal Endoplasmic Reticulum Aminopeptidase in Final Trimming of 26 S Proteasome-generated Major Histocompatability Complex Class I Antigenic Peptides J. Biol. Chem., August 3, 2001; 276(32): 30050 - 30056. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |